Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Understanding the difference in Diagnostic accuracy of MRI between ccRCC and pRCC :- A meta Analysis

View ORCID ProfileDev Desai, View ORCID ProfileSanae Majdouli, View ORCID ProfileDwija Raval, View ORCID ProfileDev Andharia, View ORCID ProfileAbhijay B. Shah, View ORCID ProfileHetvi Shah
doi: https://doi.org/10.1101/2023.06.18.23291572
Dev Desai
1Smt. NHL Municipal Medical College, Ahmedabad, India
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dev Desai
Sanae Majdouli
2Faculty of Medicine, Pharmacy, and Dentistry, University Sidi Mohamed Ben Abdellah, Morocco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sanae Majdouli
Dwija Raval
3M. K. Shah Medical College and Research Centre, Ahmedabad, India
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dwija Raval
Dev Andharia
1Smt. NHL Municipal Medical College, Ahmedabad, India
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dev Andharia
Abhijay B. Shah
1Smt. NHL Municipal Medical College, Ahmedabad, India
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abhijay B. Shah
Hetvi Shah
1Smt. NHL Municipal Medical College, Ahmedabad, India
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hetvi Shah
  • For correspondence: shahhetvi1026{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Renal cell carcinoma (RCC) comprises cancer originating from the renal epithelium and takes up for >90% of cancers in the kidney. The disease consists of >10 histological and molecular subtypes, of which clear cell RCC (ccRCC) is the most common and is responsible for most cancer-related deaths. In an attempt to ensure an early diagnosis to plan the further course of surgical intervention, pre-operative diagnosis plays an important role. MRI plays a crucial role in the diagnosis of RCC and planning for surgery for presumed RCC, especially for identifying enhanced soft tissue within renal lesions. The purpose of this meta-analysis is to ascertain the accuracy of MRI in diagnosing papillary renal cell carcinoma (pRCC) compared to clear cell carcinoma to reach a definitive diagnosis and thus, help in surgical intervention.

Methods Medical literature was comprehensively searched and reviewed without restrictions to particular study designs, or publication dates using PubMed, Cochrane Library, and Google Scholar databases for all relevant literature. The extraction of necessary data proceeded after specific inclusion and exclusion criteria were applied. In this Meta-Analysis, a total of 5 papers involving 755 lesions were considered for Clear cell carcinoma. A total number of 13 papers regarding 1009 lesions of papillary renal cell carcinoma were considered. wherein two writers independently assessed the caliber of each study as well as the use of the Cochrane tool for bias risk apprehension. The statistical software packages RevMan (Review Manager, version 5.3), SPSS (Statistical Package for the Social Sciences, version 20), and Excel in Stata 14 were used to perform the statistical analyses.

Results We calculated the sensitivity and specificity of MRI in diagnosing pRCC and ccRCC in the different papers, For the MRI in ccRCC, The sensitivity is 0.81 with a CI of 95% in a range of 0.77 to 0.86, the mean being 0.049. The Specificity of the MRI is 0.77 with a CI of 95% in a range of 0.68 to 0.86, the mean being 0.091. For the pRCC, The Sensitivity of the MRI in pRCC is 0.66 with a CI of 95% in a range of 0.52 to 0.80; the mean being (0.14). The Specificity of the MRI in pRCC is 0.87 with a CI of 95% in a range of 0.80 to 0.94, the mean being 0.072.

Conclusion Magnetic resonance imaging (MRI) offers a thorough evaluation of renal masses that takes in to account both, functional factors and several types of tissue contrast. In light of the above mentioned clinical requirements, these characteristics of MRI have sped up the process of early detection, diagnosis, staging, and evaluation of the aggressiveness and therapeutic r esponse of RCC

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This submission is a meta-analysis that has all the data used in the study recorded and referenced in the reference section.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Email Address: devhdesai01{at}gmail.com, Mob No.:- +91 9173655551

  • Email Address: sanaem30{at}gmail.com

  • Email Address: dwijaraval2005{at}gmail.com

  • Email Address: devu.andharia98{at}gmail.com

  • Email Address: abhijayshah0610{at}gmail.com

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 19, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Understanding the difference in Diagnostic accuracy of MRI between ccRCC and pRCC :- A meta Analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Understanding the difference in Diagnostic accuracy of MRI between ccRCC and pRCC :- A meta Analysis
Dev Desai, Sanae Majdouli, Dwija Raval, Dev Andharia, Abhijay B. Shah, Hetvi Shah
medRxiv 2023.06.18.23291572; doi: https://doi.org/10.1101/2023.06.18.23291572
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Understanding the difference in Diagnostic accuracy of MRI between ccRCC and pRCC :- A meta Analysis
Dev Desai, Sanae Majdouli, Dwija Raval, Dev Andharia, Abhijay B. Shah, Hetvi Shah
medRxiv 2023.06.18.23291572; doi: https://doi.org/10.1101/2023.06.18.23291572

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)